Tandem Occlusion After Emergent Stenting in Acute Ischemic Stroke

NCT ID: NCT06120218

Last Updated: 2024-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-01

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In acute ischemic stroke due to tandem occlusion, the emergent stenting has recently become an endovascular treatment option combining with mechanical thrombectomy to achieve recanalization. However, the data on the beneficial endovascular management of tandem occlusion in two circulations is still limited. The purpose of our study was to compare the improvement of clinical outcome between two circulations after emergent stenting at 3 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The posterior circulation (about 20 - 25%) is less frequent than the anterior one in the acute ischemic stroke, but high mortality and morbidity in the acute vertebrobasilar thrombosis even successful recanalization are revealed. Besides, tandem occlusion is one of the complex lesions in large vessel occlusions relating to the poor outcome, particularly in the posterior circulation. Recent studies have suggested that emergent stenting could be used as an additional treatment to achieve permanent recanalization together with mechanical thrombectomy in the intracranial segments. Permanent recanalization is one of the most important factors that impact patient outcomes after acute ischemic stroke. However, although there are various approaches for this lesion, the comparision of the effectiveness in the two circulations remains unclear. Thus, the aims of our study were to compare baseline characteristics and clinical outcome of tandem occlusions between anterior and posterior circulation after emergent stenting in extracranial arteries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Stroke Ischemic Stroke, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emergent Stenting in Anterior circulation

Emergent Carotid Stenting in acute ischemic stroke caused by tandem occlusions

Group Type EXPERIMENTAL

Emergent Stenting

Intervention Type PROCEDURE

Emergent Stenting in acute ischemic stroke caused by tandem occlusions

Emergent Stenting in Posterior circulation

Emergent Extracranial Vertebral Stenting in acute ischemic stroke caused by tandem occlusions

Group Type EXPERIMENTAL

Emergent Stenting

Intervention Type PROCEDURE

Emergent Stenting in acute ischemic stroke caused by tandem occlusions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emergent Stenting

Emergent Stenting in acute ischemic stroke caused by tandem occlusions

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years old
* Premorbid mRS \< 2
* NIHSS \> 5
* ASPECTS ≥ 5 or pc-ASPECTS ≥ 5

Exclusion Criteria

* Onset to treatment time \> 24 hours
* Loss to follow up after discharge
Minimum Eligible Age

19 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Can Tho Stroke International Services Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Cuong Tran Chi

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cuong Tran Chi, Doctor

Role: STUDY_DIRECTOR

Can Tho Stroke International Services General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Can Tho Stroke International Services Hospital

Can Tho, , Vietnam

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Vietnam

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cuong Tran Chi, Doctor

Role: CONTACT

+84886559911

Can Tho Stroke International Services Hospital

Role: CONTACT

+84886559911

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cuong Tran Chi, Doctor

Role: primary

+84886559911

References

Explore related publications, articles, or registry entries linked to this study.

Allard J, Delvoye F, Pop R, Labreuche J, Maier B, Marnat G, Sibon I, Zhu F, Lapergue B, Consoli A, Spelle L, Denier C, Richard S, Piotin M, Gory B, Mazighi M; ETIS Investigators. 24-Hour Carotid Stent Patency and Outcomes After Endovascular Therapy: A Multicenter Study. Stroke. 2023 Jan;54(1):124-131. doi: 10.1161/STROKEAHA.122.039797. Epub 2022 Dec 21.

Reference Type BACKGROUND
PMID: 36542074 (View on PubMed)

Han N, Ma L, Zhao L, Xu G, Jia Y, Wang H. The Dilator-Dotter technique can successfully treat tandem lesions of posterior circulation. Medicine (Baltimore). 2024 Jan 26;103(4):e37044. doi: 10.1097/MD.0000000000037044.

Reference Type BACKGROUND
PMID: 38277540 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TOESIS Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.